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Abstract
We describe a case of a solid variant of serous cystadenoma of the pancreas.
The preoperative examination results led to a diagnosis of a nonfunctional
pancreatic islet cell tumour, and the patient underwent a pylorus-preserving
pancreaticoduodenectomy. The tumour was diagnosed as a solid variant of
serous cystadenoma by histopathological examination. Solid variant of serous
cystadenoma of the pancreas is difficult to diagnose preoperatively. More cases
must be accumulated and investigated to obtain clues for accurate diagnosis.
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Introduction
The solid variant of serous cystadenoma (SC) was first described by
Perez-Ordonez in 1994 [1], and the tumour was defined as a solid tumour
with cytological features of serous microcystic adenoma. Because solid
variant SC is very rare, it is difficult to diagnose preoperatively. Magnetic
resonance imaging (MRI) was reported to be useful for accurate diagnosis
[2], but a definite consensus has not been reached. Here, we present our
patient and review previous cases.
Case report
A 72-year-old woman was found to have a 2 cm tumour in the
pancreatic head based on an ultrasound examination. Unenhanced
computed tomography (CT) demonstrated a 2 cm low-density tumour in
the pancreatic head (Figure 1A). It was strongly enhanced in the early phase
of contrast-enhanced CT (Figure 1B), and the enhanced effect was
prolonged to the late phase (Figure 1C). With MRI, it displayed a high
intensity on the T2-weighted image (Figure 2). When we inspected the
tumour using endoscopic ultrasonography (EUS), no cyst was recognized.
Serum concentrations of glucagon and gastrin were normal. Therefore, we
suspected a non-functional pancreatic islet cell tumour and performed
a pylorus-preserving pancreaticoduodenectomy (PPPD). In the resected
specimen, the tumour appeared clearly demarcated and solid, and it was
1.7 × 1.3 cm in size. No cyst was recognizable with the naked eye (Figure 3).
The tumour had histopathological features of SC (Figure 4). There was no
evidence of malignancy. The final diagnosis was solid variant of SC of the
pancreas. Written consent was obtained from the patient for publication
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Solid variant of SC is very rare; only eight cases,
including our case, have been reported (Table I) 
[1-7]. As with the other pancreatic tumours, it is very
difficult to make an accurate diagnosis of SC [8-11],
because there are no characteristic symptoms; the
Figure 1. Unenhanced CT demonstrated a low-density
tumour of 2 cm in the area between the pancreatic
head and the second portion of the duodenum (A).
The tumour was strongly enhanced in the early phase
of contrast-enhanced CT (B), and the enhanced effect
was prolonged to the late phase (C)
Figure  4.  Histopathological examination of the
tumour (haematoxylin/eosin stain). (A) Low magni  -
fication (×40) and (B) high magnification (×200).
Histopathological examination demonstrated that
the tumour was surrounded by a wall, like a capsule,
and was composed of a large number of small cysts.
The walls of the cysts were cubic cells that had
a small, round nucleus and pale-coloured cytoplasm.
There was no evidence of malignancy
Figure 3. The tumour existed in the pancreatic head.
It appeared clearly demarcated and solid, and it was
1.7 × 1.3 cm in size. No cyst was recognized with the
naked eye
Figure 2. The tumour displayed a high intensity on
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identified cases were accompanied by non-specific
abdominal pain or were discovered during
examinations for other diseases. Distal pan  -
creatomy or PPPD was performed based on tumour
location, except for one enucleation. Solid variant
of SC is difficult to diagnose preoperatively, and the
tumour was diagnosed as an islet cell tumour in
most of the previous cases. We also diagnosed the
tumour preoperatively as a non-functional islet cell
tumour because it was strongly enhanced on
contrast-enhanced CT, and no cystic lesion was
observed. In the previous cases, the enhancing
effect on CT was characteristic of solid serous
adenoma, but this feature is also recognized in islet
cell tumours and acinar cell tumours; therefore, it
is not a definitive clue for diagnosis. Solid variant
of SC was proposed as a preoperative diagnosis in
only one previous case [2], in which it was reported
that MR cholangiopancreatography (MRCP) was
useful for diagnosis. The signal intensity of the
pancreatic tumour remained higher than that of
the cavernous haemangioma and equal to that of
the hepatic cyst, which were detected incidentally
on MRCP, and the investigators considered that the
tumour was not a solid tumour, but a purely cystic
tumour. According to these views, a solid type of
SC was suspected. Magnetic resonance imaging
was performed in our case as well, but no
haemangioma or cyst was observed in the liver, so
we could not observe the findings. Magnetic
resonance imaging was not performed for the other
6 cases. We diagnosed the tumour preoperatively
as a non-functional islet cell tumour and performed
PPPD because approximately two-thirds of non-
functional pancreatic islet cell tumours are
malignant. However, a less invasive intervention,
such as partial pancreatomy or observation without
surgery, can be selected if the tumour is diagnosed
accurately.
In conclusion, we encountered a rare pancreatic
tumour, solid variant of SC, but it was difficult to
diagnose preoperatively. Accurate diagnosis is
important for deciding the surgical method, so more
cases must be accumulated and investigated to
obtain clues for accurate diagnosis.
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Age SexS ymptomP reoperative diagnosis Location Size [cm] CT (U/E) MRI (T1/T2) Operation
70 F Abd. pain Pancreatic islet tumour Body 4.0 – – DP
50 M Abd. pain Pancreatic islet tumour Head 2.5 – – Unknown
58 F None Pancreatic islet tumour Body 2.0 –/High – DP
59 F Abd. pain Solid SC Body 2.0 Low/High Low/High DP
66 M None Pancreatic islet tumour Head 4.0 –/High – PPPD
74 M None Pancreatic islet tumour Body 1.6 –/High – Enucleation
62 M Abd. pain Pancreatic islet tumour Body 4.2 –/High – DP
72 F None Pancreatic islet tumour Head 1.7 Low/High –/High PPPD
Abd. pain – abdominal pain, SC – serous cystadenoma, CT (U/E) – CT (unenhanced/enhanced), PPPD – pylorus preserved pancreaticoduodenectomy,
DP – distal pancreatomy 
Table I. Eight cases of solid variant of serous cystadenoma